China's Sinovac Biotech has secured approximately USD500 million in funding for Covid-19 vaccine development from Sino Biopharmaceutical.
In a statement, the company said it expects to be able to manufacture 300 million vaccine doses annually, and aims to complete construction of a second production facility by the end . . .
Please Login to read all contents for free.
Leave a Reply